Posts tagged as: InterActive Corp. back to homepage

Webxu Lower P/E Ratio than Industry Peers and a True Value Proposition Webxu Lower P/E Ratio than Industry Peers and a True Value Proposition(0)

Initial Public Offerings and Internet stocks have been the talk of the market over the last year as the stock market is experiencing the next generation of an Internet boom. While most everyone knows about companies such as Zynga (NASDAQ: ZNGA) and Groupon (NYSE: GRPN), the fact remains that plenty of other companies in the Internet space focused on analytics and customer acquisition have performed far better in ROI. Read More

Webxu Undervalued After Earnings Release Webxu Undervalued After Earnings Release(0)

Webxu Inc. (OTCBB: WBXU), is a performance media company that develops, owns and operates a network of branded consumer websites in categories marked by high consumer engagement and strong advertising spending. Operating in the digital media industry with companies like IAC/InterActive Corp (NASDAQ: IACI), Webxu appears to be significantly undervalued after unveiling its 2011 earnings Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.